4.2 Article

Interstitial Deletion of 14q24.3-q32.2 in a Male Patient With Plagiocephaly, BPES Features, Developmental Delay, and Congenital Heart Defects

Journal

AMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume 155A, Issue 1, Pages 203-206

Publisher

WILEY
DOI: 10.1002/ajmg.a.33766

Keywords

14q; BPES; developmental delay; interstitial deletion

Funding

  1. Lundbeck Foundation [R67-2010-6206] Funding Source: researchfish

Ask authors/readers for more resources

Distal interstitial deletions of chromosome 14 involving the 14q24-q23.2 region are rare, and only been reported so far in 20 patients. Ten of these patients were analyzed both clinically and genetically. Here we present a de novo interstitial deletion of chromosome 14q24.3-q32.2 in a male patient with developmental delay, language impairment, plagiocephaly, BPES features (blepharophimosis, ptosis, epicanthus), and congenital heart defect. The deletion breakpoints were fine mapped using fluorescence in situ hybridization (FISH) and the size of the deletion is estimated to be approximately 23 Mb. Based on genotype-phenotype comparisons of the 10 previously published patients and the present case, we suggest that the shortest regions for deletion overlap may include candidate genes for speech impairment, mental retardation, and hypotonia. (C) 2010 Wiley-Liss, Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Genetics & Heredity

Biochemical analysis of novel NAA10 variants suggests distinct pathogenic mechanisms involving impaired protein N-terminal acetylation

Nina McTiernan, Lisbeth Tranebjaerg, Anna S. Bjorheim, Jacob S. Hogue, William G. Wilson, Berkley Schmidt, Melissa M. Boerrigter, Maja L. Nybo, Marie F. Smeland, Zeynep Tumer, Thomas Arnesen

Summary: This study provides important insights into how different NAA10 missense variants impact the biochemical functions of NAA10 and explains the phenotypic variability in affected individuals.

HUMAN GENETICS (2022)

Article Genetics & Heredity

The clinical and molecular spectrum of QRICH1 associated neurodevelopmental disorder

Smitha Kumble, Amanda M. Levy, Jaya Punetha, Hua Gao, Nicholas Ah Mew, Kwame Anyane-Yeboa, Paul J. Benke, Sara M. Berger, Lise Bjerglund, Belinda Campos-Xavier, Michael Ciliberto, Julie S. Cohen, Anne M. Comi, Cynthia Curry, Lena Damaj, Anne-Sophie Denomme-Pichon, Lisa Emrick, Laurence Faivre, Mary Beth Fasano, Alice Fievet, Richard S. Finkel, Sixto Garcia-Minaur, Amanda Gerard, Paulino Gomez-Puertas, Maria J. Guillen Sacoto, Trevor L. Hoffman, Lillian Howard, Alejandro D. Iglesias, Kosuke Izumi, Austin Larson, Anja Leiber, Reymundo Lozano, Inigo Marcos-Alcalde, Cassie S. Mintz, Sureni V. Mullegama, Rikke S. Moller, Sylvie Odent, Henry Oppermann, Elsebet Ostergaard, Marta Pacio-Miguez, Maria Palomares-Bralo, Sumit Parikh, Anna M. Paulson, Konrad Platzer, Jennifer E. Posey, Lorraine Potocki, Anya Revah-Politi, Marlene Rio, Alyssa L. Ritter, Scott Robinson, Jill A. Rosenfeld, Fernando Santos-Simarro, Sergio B. Sousa, Mathys Weber, Yili Xie, Wendy K. Chung, Natasha J. Brown, Zeynep Tumer

Summary: De novo variants in QRICH1 have been identified in individuals with intellectual disability, contributing to a neurodevelopmental disorder. The common clinical features include developmental delay, facial dysmorphism, and hypotonia, with additional findings of poor weight gain, short stature, autism spectrum disorder, seizures, and scoliosis. Some variants are inherited from mildly affected parents, suggesting variable expressivity.

HUMAN MUTATION (2022)

Article Psychiatry

Concordance and comorbidities among monozygotic twins with tic disorders

Julie Holst Pedersen, Axel Skytthe, Jonas Bybjerg-Grauholm, Asli Sena Kucukyildiz, Liselotte Skov, Nanette Mol Debes, Zeynep Tumer

Summary: Gilles de la Tourette Syndrome (GTS) is a multifactorial neurodevelopmental disorder characterized by tics and multiple comorbidities. Twin studies indicate that both genetic and environmental risk factors are involved. The study found high concordance of GTS and chronic tic disorders in monozygotic twins, suggesting common genetic risk factors. The findings also showed higher comorbidity rates in twins with GTS or CTD compared to the general population.

JOURNAL OF PSYCHIATRIC RESEARCH (2022)

Article Genetics & Heredity

Biallelic variants in ZNF142 lead to a syndromic neurodevelopmental disorder

Maria B. Christensen, Amanda M. Levy, Nazanin A. Mohammadi, Marcello Niceta, Rauan Kaiyrzhanov, Maria Lisa Dentici, Chadi Al Alam, Viola Alesi, Valerie Benoit, Kailash P. Bhatia, Tatjana Bierhals, Christian M. Bosselmann, Julien Buratti, Bert Callewaert, Berten Ceulemans, Perrine Charles, Matthias De Wachter, Mohammadreza Dehghani, Erika D'haenens, Martine Doco-Fenzy, Michaela Gessner, Cyrielle Gobert, Ulviyya Guliyeva, Tobias B. Haack, Trine B. Hammer, Tilman Heinrich, Maja Hempel, Theresia Herget, Ute Hoffmann, Judit Horvath, Henry Houlden, Boris Keren, Christina Kresge, Candy Kumps, Damien Lederer, Alban Lermine, Francesca Magrinelli, Reza Maroofian, Mohammad Yahya Vahidi Mehrjardi, Mahdiyeh Moudi, Amelie J. Mueller, Anna J. Oostra, Beth A. Pletcher, David Ros-Pardo, Shanika Samarasekera, Marco Tartaglia, Kristof Van Schil, Julie Vogt, Evangeline Wassmer, Juliane Winkelmann, Maha S. Zaki, Michael Zech, Holger Lerche, Francesca Clementina Radio, Paulino Gomez-Puertas, Rikke S. Moller, Zeynep Tuemer

Summary: Biallelic variants of the ZNF142 gene have been associated with intellectual disability, speech impairment, seizures, and movement disorders. This study expands on previous research by providing phenotype and genotype information of 26 individuals from 16 families. The clinical features of the individuals suggest a syndromic neurodevelopmental disorder with mild to moderate intellectual disability, language and gross motor development delays, seizures, hypotonia, behavioral features, movement disorders, and facial dysmorphism.

CLINICAL GENETICS (2022)

Review Biochemistry & Molecular Biology

Neurodevelopmental Disorders Associated with PSD-95 and Its Interaction Partners

Amanda M. Levy, Paulino Gomez-Puertas, Zeynep Tumer

Summary: The protein PSD-95 plays a crucial role in synaptic strength and plasticity, and its variants have been found to cause neurodevelopmental disorders. These variants may indirectly affect the interaction partners of PSD-95, leading to overlapping clinical features. This review explores the association between PSD-95 and its transmembrane interaction partners, and discusses the impact of DLG4 missense variants on protein-protein interactions and the pathogenic mechanism.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Genetics & Heredity

Maternal versus paternal inheritance of a 132 bp 11p15.5 microdeletion affecting KCNQ1OT1 and associated phenotypes

Ulrik Kristoffer Stoltze, Thomas Van Overeem Hansen, Jesper Sune Brok, Karen Gronskov, Asuman Z. Turner, Lise Barlebo Ahlborn, Kjeld Schmiegelow, Karin A. W. Wadt

JOURNAL OF MEDICAL GENETICS (2023)

Article Genetics & Heredity

DNA methylation signature classification of rare disorders using publicly available methylation data

Mathis Hildonen, Marco Ferilli, Tina Duelund Hjortshoj, Morten Duno, Lotte Risom, Mads Bak, Jakob Ek, Rikke. S. S. Moller, Andrea Ciolfi, Marco Tartaglia, Zeynep Tumer

Summary: Disease-specific DNA methylation patterns (DNAm signatures) have been established for an increasing number of genetic disorders and can be used as a valuable tool for classification of genetic variants of uncertain significance (VUS). This study demonstrates the clinical utility of a robust DNAm signature and highlights the importance of data sharing for improved diagnosis of rare genetic disorders.

CLINICAL GENETICS (2023)

Article Medicine, General & Internal

Cell-free fetal DNA for genetic evaluation in Copenhagen Pregnancy Loss Study (COPL): a prospective cohort study

Tanja Schlaikjaer Hartwig, Louise Ambye, Jennifer R. Gruhn, Jesper Friis Petersen, Tine Wronding, Letizia Amato, Andrew Chi-Ho Chan, Boyang Ji, Maiken Hemme Bro-Jorgensen, Lene Werge, Mette Marie Babiel Schmidt Petersen, Clara Brinkmann, Julie Birch Petersen, Morten Duno, Iben Bache, Markus J. Herrgard, Finn Stener Jorgensen, Eva R. Hoffmann, Henriette Svarre Nielsen

Summary: This study validates the feasibility of using cell-free fetal DNA (cffDNA) from maternal blood for the detection of fetal aneuploidy in cases of pregnancy loss. The results show that this method has a high sensitivity and specificity in distinguishing between euploid and aneuploid pregnancy loss, providing valuable information for clinical management.

LANCET (2023)

Article Genetics & Heredity

Involvement of Mitochondrial Dysfunction in FOXG1 Syndrome

Victoria A. Bjerregaard, Amanda M. Levy, Mille S. Batz, Ravina Salehi, Mathis Hildonen, Trine B. Hammer, Rikke S. Moller, Claus Desler, Zeynep Tumer

Summary: FOXG1 (Forkhead box g1) syndrome is a neurodevelopmental disorder caused by a defective transcription factor, FOXG1, which is important for normal brain development and function. This study found that individuals with FOXG1 variants had decreased mitochondrial content and adenosine triphosphate (ATP) levels, as well as morphological changes in the mitochondrial network, indicating mitochondrial dysfunction as a possible factor in the pathogenesis of FOXG1 syndrome. Further research is needed to understand how FOXG1 deficiency affects mitochondrial homeostasis.

GENES (2023)

Article Genetics & Heredity

Germline (epi)genetics reveals high predisposition in females: a 5-year, nationwide, prospective Wilms tumour cohort

Ulrik Kristoffer Stoltze, Mathis Hildonen, Thomas Van Overeem Hansen, Jon Foss-Skiftesvik, Anna Byrjalsen, Malene Lundsgaard, Laura Pignata, Karen Gronskov, Asuman Z. Tumer, Kjeld Schmiegelow, Jesper Sune Brok, Karin A. W. Wadt

Summary: This study found that the development of Wilms tumors is associated with genetic and epigenetic factors, with female patients more likely to carry pathogenic variants. Early detection of underlying predisposition may have important implications for diagnosis, treatment, and genetic counseling for Wilms tumors.

JOURNAL OF MEDICAL GENETICS (2023)

Article Psychiatry

Polygenic risk score-based phenome-wide association study identifies novel associations for Tourette syndrome

Pritesh Jain, Tyne Miller-Fleming, Apostolia R. Topaloudi, Dongmei K. Yu, Petros Drineas, Marianthi Georgitsi, Zhiyu Yang, Renata Rizzo, Kirsten R. Mueller-Vahl, Zeynep A. Tumer, Nanette Mol Debes, Andreas S. Hartmann, Christel E. Depienne, Yulia S. Worbe, Pablo Mir, Danielle C. Cath, Dorret Boomsma, Veit Roessner, Tomasz Wolanczyk, Piotr Janik, Natalia Szejko, Cezary Zekanowski, Csaba Barta, Zsofia Nemoda, Zsanett Tarnok, Joseph D. Buxbaum, Dorothy Grice, Jeffrey Glennon, Hreinn Stefansson, Bastian Hengerer, Noa Benaroya-Milshtein, Francesco Cardona, Tammy Hedderly, Isobel Heyman, Chaim Huyser, Astrid Morer, Norbert Mueller, Alexander Munchau, Kerstin J. Plessen, Cesare Porcelli, Susanne Walitza, Anette Schrag, Davide Martino, Andrea Dietrich, Carol A. Mathews, Jeremiah M. Scharf, Pieter J. Hoekstra, Lea K. Davis, Peristera Paschou

TRANSLATIONAL PSYCHIATRY (2023)

Article Genetics & Heredity

A deep intronic DLG4 variant resulting in DLG4-related synaptopathy

Amanda M. Levy, Mythily Ganapathi, Wendy K. K. Chung, Zeynep Tumer

Summary: The rare brain disorder DLG4-related synaptopathy is caused by de novo variants in DLG4, primarily resulting in protein-truncating changes. However, there are also DLG4 variants predicted to affect RNA splicing, and their pathogenicity remains uncertain without functional RNA studies. This study describes a case where a deep intronic DLG4 variant was identified using whole genome sequencing and subsequent functional analysis revealed alternative DLG4 transcripts that lead to protein-truncation.

CLINICAL GENETICS (2023)

Article Medicine, General & Internal

Imprinting disorders

Thomas Eggermann, David Monk, Guiomar Perez de Nanclares, Masayo Kagami, Eloise Giabicani, Andrea Riccio, Zeynep Tumer, Jennifer M. Kalish, Maithe Tauber, Jessica Duis, Rosanna Weksberg, Eamonn R. Maher, Matthias Begemann, Miriam Elbracht

Summary: This article summarizes the molecular mechanisms, diagnosis, and treatment of imprinting disorders. It also provides an overview of future research and the impact of these disorders on patient quality of life. Imprinting disorders are congenital conditions characterized by disturbances in genomic imprinting. The most common types include Prader-Willi, Angelman, and Beckwith-Wiedemann syndromes. Diagnosis is challenging due to the non-specific clinical manifestations, and treatment is currently symptomatic. Personalized therapies are being developed to address the rarity of these disorders.

NATURE REVIEWS DISEASE PRIMERS (2023)

Meeting Abstract Biochemistry & Molecular Biology

Multilocus Imprinting Disturbance (MLID) testing in imprinting disorders: Joint position statement to standardize diagnostic testing for MLID

Thomas Eggermann, Deborah Mackay, Karen Temple, David Monk, Eamonn Maher, Andrea Riccio, Frederic Brioude, Agnes Linglart, Matthias Begemann, Katja Eggermann, Miriam Elbracht, Karen Gronskov, Jet Bliek, Paola Lombardi, Guiomar Perez de Nanclares, Masayo Kagami, Irene Netchine, Tsutomu Ogata, Zeynep Tumer

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

Meeting Abstract Biochemistry & Molecular Biology

An innovative e-training tool for the clinical management of NDD, the DefiGame serious game

Anne Hugon, C. Immesoete, B. Chaumette, J. Clayton-Smith, C. Cravero, S. Daugy, D. Dan, S. Douzgou Houge, L. Faivre, S. Heide, R. C. Hennekam, T. Kleefstra, L. Laporte, I. Marchetti-Waternaux, A. Manunta, G. Mosiello, S. Peudenier, V. Des Portes, M. P. Reymond, S. Selatnia, A. Sundqvist, M. Tartaglia, Z. Tumer, B. Tumiene, L. Vissers, K. Vyshka, D. Wieczorek, G. Zampino, A. Renieri, A. Verloes

EUROPEAN JOURNAL OF HUMAN GENETICS (2022)

No Data Available